Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/32197
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-04-05T11:17:29Z | - |
dc.date.available | 2023-04-05T11:17:29Z | - |
dc.date.issued | 2015-11-25 | - |
dc.identifier.citation | Çekiç, Ş. ve Kılıç, S. Ş. (2016). "Iloprost treatment in pediatric patients with complicated Raynaud's phenomenon". Lupus, 25(5), 558-560. | en_US |
dc.identifier.issn | 0961-2033 | - |
dc.identifier.issn | 1477-0962 | - |
dc.identifier.uri | https://doi.org/10.1177/0961203315622898 | - |
dc.identifier.uri | https://journals.sagepub.com/doi/10.1177/0961203315622898 | - |
dc.identifier.uri | http://hdl.handle.net/11452/32197 | - |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Rheumatology | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Age of onset | en_US |
dc.subject.mesh | Antiphospholipid syndrome | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Foot | en_US |
dc.subject.mesh | Foot ulcer | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Iloprost | en_US |
dc.subject.mesh | Ischemia | en_US |
dc.subject.mesh | Raynaud disease | en_US |
dc.subject.mesh | Regional blood flow | en_US |
dc.subject.mesh | Treatment outcome | en_US |
dc.subject.mesh | Vasoconstriction | en_US |
dc.subject.mesh | Vasodilator agents | en_US |
dc.subject.mesh | Wound healing | en_US |
dc.title | Iloprost treatment in pediatric patients with complicated Raynaud's phenomenon | en_US |
dc.type | Letter | en_US |
dc.identifier.wos | 000372150400015 | tr_TR |
dc.identifier.scopus | 2-s2.0-84962529394 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Çocuk İmmünolojisi ve Romatoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-9574-1842 | tr_TR |
dc.contributor.orcid | 0000-0001-8571-2581 | tr_TR |
dc.identifier.startpage | 558 | tr_TR |
dc.identifier.endpage | 560 | tr_TR |
dc.identifier.volume | 25 | tr_TR |
dc.identifier.issue | 5 | tr_TR |
dc.relation.journal | Lupus | en_US |
dc.contributor.buuauthor | Çekiç, Şükrü | - |
dc.contributor.buuauthor | Kılıç, Sara Şebnem | - |
dc.contributor.researcherid | L-1933-2017 | tr_TR |
dc.contributor.researcherid | AAH-1658-2021 | tr_TR |
dc.identifier.pubmed | 26692039 | tr_TR |
dc.subject.wos | Rheumatology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 56117061000 | tr_TR |
dc.contributor.scopusid | 34975059200 | tr_TR |
dc.subject.emtree | C reactive protein | en_US |
dc.subject.emtree | D dimer | en_US |
dc.subject.emtree | Dipyridamole | en_US |
dc.subject.emtree | İloprost | en_US |
dc.subject.emtree | Myeloblastin | en_US |
dc.subject.emtree | Myeloperoxidase | en_US |
dc.subject.emtree | Nadroparin | en_US |
dc.subject.emtree | Neutrophil cytoplasmic antibody | en_US |
dc.subject.emtree | Nifedipine | en_US |
dc.subject.emtree | Vasodilator agent | en_US |
dc.subject.emtree | Adolescent | en_US |
dc.subject.emtree | Antiphospholipid syndrome | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Child | en_US |
dc.subject.emtree | Childhood disease | en_US |
dc.subject.emtree | Cold exposure | en_US |
dc.subject.emtree | Cyanosis | en_US |
dc.subject.emtree | Disease course | en_US |
dc.subject.emtree | Doppler echography | en_US |
dc.subject.emtree | Ecchymosis | en_US |
dc.subject.emtree | Edema | en_US |
dc.subject.emtree | Erythrocyte sedimentation rate | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Foot pain | en_US |
dc.subject.emtree | Genetic variability | en_US |
dc.subject.emtree | Hepatitis A virus | en_US |
dc.subject.emtree | Hepatitis B virus | en_US |
dc.subject.emtree | Hepatitis C virus | en_US |
dc.subject.emtree | Hospital admission | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Hyperemia | en_US |
dc.subject.emtree | Immunofluorescence | en_US |
dc.subject.emtree | Immunoglobulin blood level | en_US |
dc.subject.emtree | Letter | en_US |
dc.subject.emtree | Medical history | en_US |
dc.subject.emtree | Partial thromboplastin time | en_US |
dc.subject.emtree | Physical examination | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Protein electrophoresis | en_US |
dc.subject.emtree | Prothrombin time | en_US |
dc.subject.emtree | Raynaud phenomenon | en_US |
dc.subject.emtree | School child | en_US |
dc.subject.emtree | Treatment duration | en_US |
dc.subject.emtree | Antiphospholipid syndrome | en_US |
dc.subject.emtree | Blood flow | en_US |
dc.subject.emtree | Complication | en_US |
dc.subject.emtree | Drug effects | en_US |
dc.subject.emtree | Foot | en_US |
dc.subject.emtree | Foot ulcer | en_US |
dc.subject.emtree | Ischemia | en_US |
dc.subject.emtree | Onset age | en_US |
dc.subject.emtree | Pathophysiology | en_US |
dc.subject.emtree | Raynaud disease | en_US |
dc.subject.emtree | Treatment outcome | en_US |
dc.subject.emtree | Vascularization | en_US |
dc.subject.emtree | Vasoconstriction | en_US |
dc.subject.emtree | Wound healing | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.